Suppr超能文献

硅凝胶乳房假体植入女性患者自述的全身症状:描述性队列研究。

Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study.

机构信息

Internal Medicine, Amsterdam UMC, Locatie VUmc, Amsterdam, Noord-Holland, The Netherlands.

Department of Endocrinology, Amsterdam UMC, VUMC Location, Amsterdam, Noord-Holland, The Netherlands.

出版信息

BMJ Open. 2022 Jun 9;12(6):e057159. doi: 10.1136/bmjopen-2021-057159.

Abstract

OBJECTIVE

An unknown portion of women with silicone breast implants (SBI) report development of systemic symptoms, recently named as 'breast implant illness (BII)'. We aim to describe the symptoms and characteristics of women with SBI reporting these systemic symptoms and compare the clinical course of women who chose to keep their implants, to women who had their implants removed.

DESIGN

Observational cohort study.

SETTING

Specialised BII out-patient clinic at Amsterdam UMC, the Netherlands, from 2011 to 2020.

PARTICIPANTS

All women presenting to the BII clinic with SBI and systemic symptoms.

RESULTS

467 women were included for baseline analyses and 398 women for follow-up. Most frequently reported systemic symptoms at baseline included fatigue (88%), arthralgia (71%), morning stiffness (59%), myalgia (48%), cognitive impairment (33%), peripheral neurological symptoms (30%) and lymphadenopathy (22%). Furthermore, 56% reported pre-existing allergies at baseline and positive antinuclear antibodies were observed in 23%. At follow-up with a median of 3.3 years (IQR 2-4), 152 women had their implants removed on clinical grounds. Symptoms improved significantly in 65 women (43%), improved moderately in 37 women (24%), did not change in 37 women (24%) and deteriorated in 13 women (9%). Women who underwent explantation showed more improvement of their systemic symptoms compared with women who did not (OR 2.9, 95% CI 1.3 to 6.2). Additionally, women who underwent explantation within 10 years after implantation improved significantly better than women who got the implants removed after 10 years (p=0.007). Lastly, local symptoms decreased from 75% to 34% after implant removal (p<0.0001).

CONCLUSION

Most women with SBI who developed systemic symptoms experienced improvement after explantation, especially when removed within 10 years after implantation. Early recognition of the pattern of systemic symptoms in women with SBI is important and implant removal should be considered.

摘要

目的

部分硅胶乳房植入物(SBI)女性患者会出现全身症状,最近被称为“乳房植入物病(BII)”。本研究旨在描述出现此类全身症状的 SBI 女性患者的症状和特征,并比较选择保留植入物和取出植入物的女性患者的临床病程。

设计

观察性队列研究。

地点

荷兰阿姆斯特丹 UMC 的专门 BII 门诊,2011 年至 2020 年。

参与者

所有因 SBI 和全身症状就诊 BII 门诊的女性患者。

结果

在基线分析中纳入了 467 名女性,在随访中纳入了 398 名女性。基线时最常报告的全身症状包括疲劳(88%)、关节痛(71%)、晨僵(59%)、肌痛(48%)、认知障碍(33%)、周围神经症状(30%)和淋巴结病(22%)。此外,56%的患者在基线时有既往过敏史,23%的患者抗核抗体阳性。在中位随访 3.3 年(IQR 2-4)时,152 名女性因临床原因取出了植入物。65 名女性(43%)的症状明显改善,37 名女性(24%)的症状中度改善,37 名女性(24%)的症状无变化,13 名女性(9%)的症状恶化。与未行取出术的女性相比,行取出术的女性全身症状改善更显著(OR 2.9,95%CI 1.3 至 6.2)。此外,植入后 10 年内取出植入物的女性症状改善明显优于植入后 10 年以上取出植入物的女性(p=0.007)。最后,植入物取出后局部症状从 75%降至 34%(p<0.0001)。

结论

大多数出现全身症状的 SBI 女性患者在取出植入物后症状得到改善,尤其是在植入后 10 年内取出时。早期识别 SBI 女性全身症状的模式很重要,应考虑取出植入物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2967/9185500/7861d11dcd2b/bmjopen-2021-057159f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验